(Q33960894)

30 July 2017

1 reference

title

Controversies in the management of endometrial carcinoma (English)

1 reference

30 July 2017

main subject

endometrial carcinoma

1 reference

Ying Zhang

1

1 reference

30 July 2017

Jian Wang

series ordinal

2

1 reference

30 July 2017

publication date

22 June 2010

1 reference

Obstetrics and gynecology international

30 July 2017

published in

1 reference

30 July 2017

volume

2010

1 reference

30 July 2017

page(s)

862908

1 reference

Creative Commons Attribution 3.0 Unported

30 July 2017

copyright license

start time

1 January 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Role of the integrated FDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: detection of pelvic nodal metastases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Neoadjuvant chemotherapy followed by interval debulking surgery in patients with serous endometrial cancer with transperitoneal spread (stage IV): a new preferred treatment?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

The fertility-sparing treatment in patients with endometrial atypical hyperplasia and early endometrial cancer: a debated therapeutic option

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Gynecologic cancers in pregnancy: guidelines of an international consensus meeting

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

5 July 2018

Cancer statistics, 2009

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Present status and future direction of clinical trials in advanced endometrial carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Current challenges in clinical management of endometrial cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Laparoscopic surgery vs laparotomy for early stage endometrial cancer: long-term data of a randomized controlled trial.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Magnetic resonance imaging to identify risk of lymph node metastasis in patients with endometrial cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Concurrent carboplatin/paclitaxel and intravaginal radiation in surgical stage I-II serous endometrial cancer.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Laparoscopic radical hysterectomy with lymphadenectomy in patients with early cervical cancer: our instruments and technique

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Paclitaxel, topotecan, and carboplatin in metastatic endometrial cancinoma: a Hellenic Co-operative Oncology Group (HeCOG) study.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Phase II study of erlotinib in recurrent or metastatic endometrial cancer: NCIC IND-148.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Gynecologic cancers associated with Lynch syndrome/HNPCC.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Risk factors and adjuvant chemotherapy in the treatment of endometrial cancer.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Carboplatin and paclitaxel in advanced or metastatic endometrial cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Current issues in the management of endometrial cancer.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Survival and recurrent disease after postoperative radiotherapy for early endometrial cancer: systematic review and meta-analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Hysteroscopy in the diagnosis of postmenopausal bleeding

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Adjuvant radiotherapy for stage I endometrial cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Adjuvant radiotherapy for stage I endometrial cancer: systematic review and meta-analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Young patients with endometrial carcinoma selected for conservative treatment: a need for vigilance for synchronous ovarian carcinomas, case report and literature review

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Systemic therapy in metastatic or recurrent endometrial cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Management of endometrial cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Paclitaxel/carboplatin versus cyclophosphamide/adriamycin/cisplatin as postoperative adjuvant chemotherapy for advanced endometrial adenocarcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Paclitaxel and carboplatin in the adjuvant treatment of patients with high-risk stage III and IV endometrial cancer: a retrospective study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Prediction of lymph node metastasis in patients with endometrioid endometrial cancer using expression microarray

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Coexisting ovarian malignancy in young women with endometrial cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Microarray analysis of endometrial carcinomas and mixed mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Carboplatin and paclitaxel for the treatment of advanced or recurrent endometrial cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Fertility-sparing surgery for malignancies in women

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with "high-risk" endometrial cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Feasibility study of concurrent weekly cisplatin and whole abdominopelvic irradiation followed by doxorubicin/cisplatin chemotherapy for advanced stage endometrial carcinoma: a Gynecologic Oncology Group trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

The clinical value and the cost-effectiveness of follow-up in endometrial cancer patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Combined treatment with chemotherapy and radiotherapy in high-risk FIGO stage III-IV endometrial cancer patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Outcome of fertility-sparing treatment with progestins in young patients with endometrial cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

The effects of estradiol and selective estrogen receptor modulators on gene expression and messenger RNA stability in immortalized sheep endometrial stromal cells and human endometrial adenocarcinoma cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Survival after relapse in patients with endometrial cancer: results from a randomized trial.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Surgical management of early-stage endometrial cancer in the elderly: is laparoscopy feasible?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Endometrial cancer in women 40 years old or younger

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: a phase II study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Surgical management of advanced or recurrent endometrial cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Predictors of recurrence in surgical stage II endometrial adenocarcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Recurrence of endometrial carcinoma and the value of routine follow up.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

PTEN/MMAC1 mutations in endometrial cancers.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Costs and benefits of routine follow-up after curative treatment for endometrial cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

PTEN1 is frequently mutated in primary endometrial carcinomas

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literature

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Is there any value in the long term follow up of women treated for endometrial cancer?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Familial cancer aggregation in cases of adenocarcinoma corporis uteri

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Beta-catenin and E-cadherin expression patterns in high-grade endometrial carcinoma are associated with histological subtype.

5 July 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F862908

Polymorphisms in TP53 and MDM2 combined are associated with high grade endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F862908

18F-FDG PET in the management of endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F862908

The clinical impact of [(18)F]FDG PET/CT for the management of recurrent endometrial cancer: correlation with clinical and histological findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F862908

Accuracy of integrated FDG-PET/contrast-enhanced CT in detecting pelvic and paraaortic lymph node metastasis in patients with uterine cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F862908

Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F862908

Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F862908

Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F862908

Lymphadenectomy in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F862908

Total laparoscopic hysterectomy versus abdominal hysterectomy with lymphadenectomy for early-stage endometrial cancer: a prospective randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F862908

The outcomes of 27,063 women with unstaged endometrioid uterine cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F862908

Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F862908

Fertility-preserving treatment in young patients with endometrial adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F862908

Estrogen replacement therapy in endometrial cancer patients: a matched control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F862908

Feasibility of ovarian preservation in patients with early stage endometrial carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F862908

Outcome of fertility-preserving treatment in young women with endometrial carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F862908

Successful pregnancy after conservative surgery for stage IA endometrial cancer in a young woman

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F862908

Pregnancy following intracytoplasmic sperm injection and preimplantation genetic diagnosis after the conservative management of endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F862908

A successful pregnancy after intracytoplasmic sperm injection and embryo transfer in a patient with endometrial cancer who was treated conservatively

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F862908

Reevaluating the safety of fertility-sparing hormonal therapy for early endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F862908

Cyr61, a member of ccn (connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed) family, predicts survival of patients with endometrial cancer of endometrioid subtype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F862908

The prognostic value of molecular biomarkers in tissue removed by curettage from FIGO stage 1 and 2 endometrioid type endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F862908

Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F862908

Clinical implication of estrogen-related receptor (ERR) expression in uterine endometrial cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F862908

Cathepsin B protein levels in endometrial cancer: Potential value as a tumour biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F862908

Prospective evaluation of DNA mismatch repair protein expression in primary endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F862908

Limited clinical benefit from trastuzumab in recurrent endometrial cancer: two case reports.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F862908

Risk-specific follow-up for endometrial carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F862908

Occult endometrial cancer and decision making for prophylactic hysterectomy in hereditary nonpolyposis colorectal cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F862908

Cancer risk associated with germline DNA mismatch repair gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F862908

The role of hysteroscopy with eye-directed biopsy in postmenopausal women with uterine bleeding and endometrial atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F862908

Conservative management of a patient with endometrial carcinoma desiring fertility: how to inform?

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Postoperative adjuvant chemotherapy in surgically staged grade 3 endometrial cancer.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Differential gene expression profile in endometrioid and nonendometrioid endometrial carcinoma: STK15 is frequently overexpressed and amplified in nonendometrioid carcinomas.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Medroxyprogesterone acetate therapy for patients with adenocarcinoma of the endometrium who wish to preserve the uterus-usefulness and limitations

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896852

Randomized Phase III Trial of Whole-Abdominal Irradiation Versus Doxorubicin and Cisplatin Chemotherapy in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study

29 October 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F862908

K-ras activation in premalignant and malignant epithelial lesions of the human uterus

21 January 2018

1 reference

12 December 2020

Adjuvant Brachytherapy Removes Survival Disadvantage of Local Disease Extension in Stage IIIC Endometrial Cancer: A SEER Registry Analysis

1 reference

12 December 2020

ICSI outcome following conservative fertility sparing management of endometrial cancer

1 reference

12 December 2020

[Study of differential gene expression in different stage human endometrial cancer]

1 reference

12 December 2020

New surgical staging of endometrial cancer: 20 years later

1 reference

12 December 2020

Treatment of primary advanced and recurrent endometrial carcinoma with a combination of carboplatin and paclitaxel-long-term follow-up

1 reference

12 December 2020

Clinical behavior of 203 stage II endometrial cancer cases: The impact of primary surgical approach and of adjuvant radiation therapy

1 reference

12 December 2020

Fertility-sparing treatment in young women with endometrial cancer or atypical complex hyperplasia: a prospective single-institution experience of 21 cases

1 reference

12 December 2020

Recurrent endometrial cancer: a retrospective study

1 reference

12 December 2020

Detection of deep myometrial invasion in endometrial carcinoma: comparison of transvaginal ultrasound, CT, and MRI

1 reference

12 December 2020

Hysteroscopy is not warrented as a first line investigation for postmenopausal bleeding

1 reference

12 December 2020

[Hysteroscopy findings in patients with postmenopausal genital bleeding]

1 reference

12 December 2020

E-cadherin expression in endometrioid, papillary serous, and clear cell carcinoma of the endometrium

1 reference

12 December 2020

Clinicopathologic significance of DNA mismatch repair defects in endometrial cancer: the devil is in the details

1 reference

12 December 2020

Young patients with endometrial cancer: how many could be eligible for fertility-sparing treatment?

1 reference

12 December 2020

Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40

1 reference

12 December 2020

Ovarian preservation during the surgical treatment of early stage endometrial cancer: A nation-wide study conducted by the Korean Gynecologic Oncology Group

1 reference

12 December 2020

Comparison of the molecular classification with FIGO stage and histological grade on endometrial cancer

1 reference

12 December 2020

Role of hysteroscopy with endometrial biopsy to rule out endometrial cancer in postmenopausal women with abnormal uterine bleeding

1 reference

12 December 2020

Pelvic and para-aortic lymphadenectomy in patients with endometrioid adenocarcinoma of the endometrium

1 reference

12 December 2020

Clinical and pathologic correlates in surgical stage II endometrial carcinoma

1 reference

12 December 2020

MMP-2, TIMP-1, E-cadherin, and beta-catenin expression in endometrial serous carcinoma compared with low-grade endometrial endometrioid carcinoma and proliferative endometrium

1 reference

12 December 2020

K-ras mutations in endometrial carcinomas with microsatellite instability

1 reference

12 December 2020

Feasibility, morbidity, and safety of total laparoscopic radical hysterectomy with lymphadenectomy: our experience

1 reference

12 December 2020

Prophylactic Surgery to Reduce the Risk of Gynecologic Cancers in the Lynch Syndrome

1 reference

12 December 2020

1 reference

12 December 2020

Value and cost evaluation of routine follow-up for patients with clinical stage I/II endometrial cancer

1 reference

12 December 2020

Transvaginal ultrasonography and uterine artery Doppler in diagnosing endometrial pathologies and carcinoma in postmenopausal bleeding

1 reference

12 December 2020

Updating of a recent meta-analysis of randomized controlled trials to assess the safety and the efficacy of the laparoscopic surgery for treating early stage endometrial cancer

1 reference

12 December 2020

Total laparoscopic radical hysterectomy (type III) and pelvic lymphadenectomy

1 reference

12 December 2020

Can primary endometrial carcinoma stage I be cured without surgery and radiation therapy?

1 reference

12 December 2020

Chemotherapy (CT) with radiotherapy versus CT alone for FIGO Stage IIIc endometrial cancer

1 reference

12 December 2020

Conservative treatment of endometrial cancer permitting subsequent triplet pregnancy

1 reference

12 December 2020

Endometrial cancer: adjuvant treatment of endometrial cancer--radiotherapy, chemotherapy or both

1 reference

12 December 2020

Molecular Analysis of Familial Endometrial Carcinoma: A Manifestation of Hereditary Nonpolyposis Colorectal Cancer or a Separate Syndrome?

1 reference

12 December 2020

Intravaginal brachytherapy in FIGO stage I low-risk endometrial cancer: a controlled randomized study

1 reference

12 December 2020

Optimizing the management of stage II endometrial cancer: the role of radical hysterectomy and radiation

1 reference

12 December 2020

Role of wide/radical hysterectomy and pelvic lymph node dissection in endometrial cancer with cervical involvement

1 reference

12 December 2020

Gene Expression Profiles of Serous, Endometrioid, and Clear Cell Subtypes of Ovarian and Endometrial Cancer

1 reference

12 December 2020

The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways

1 reference

12 December 2020

Adjuvant carboplatin and paclitaxel chemotherapy interposed with involved field radiation for advanced endometrial cancer

1 reference

12 December 2020

Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group Study

1 reference

12 December 2020

p53 protein overexpression is a prognostic indicator of poor survival in stage I endometrial carcinoma

1 reference

12 December 2020

Final analysis of RTOG 9708: Adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer

1 reference

12 December 2020

Safety of ovarian preservation in premenopausal women with endometrial cancer

1 reference

12 December 2020

Her-2/neu overexpression and amplification in uterine papillary serous carcinoma

1 reference

12 December 2020

Microsatellite instability and hMLH1/hMSH2 expression in young endometrial carcinoma patients: associations with family history and histopathology

1 reference

12 December 2020

Significant pelvic recurrence in high-risk pathologic stage I–IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy

1 reference

12 December 2020

Phase I trial of the treatment of high-risk endometrial cancer with concurrent weekly paclitaxel and cisplatin and whole abdominal radiation therapy: a Gynecologic Oncology Group study

1 reference

12 December 2020

[Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)]

1 reference

12 December 2020

A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study

1 reference

12 December 2020

Loss of phosphatase and tensin homologue deleted on chromosome 10 and phosphorylation of mammalian target of rapamycin are associated with progesterone refractory endometrial hyperplasia

1 reference

12 December 2020

HER2/neu overexpression: has the Achilles' heel of uterine serous papillary carcinoma been exposed?

1 reference

12 December 2020

Gene expression profiling of microsatellite unstable and microsatellite stable endometrial cancers indicates distinct pathways of aberrant signaling

1 reference

12 December 2020

Identifiers

DOI

10.1155/2010/862908

1 reference

30 July 2017

1 reference

30 July 2017

1 reference